- $2.07bn
- $1.54bn
- $874.18m
- 94
- 40
- 98
- 92
Annual cashflow statement for Argan, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
C2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 23.8 | 35.7 | 34.7 | 32.4 | 85.5 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.58 | 14.2 | 1.21 | 0.884 | 6.72 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 136 | -25.5 | -69 | 78 | 67.9 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 176 | 28.4 | -30.1 | 117 | 168 |
| Capital Expenditures | -1.7 | -1.42 | -3.37 | -2.76 | -6.58 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 68.7 | -5.62 | -59.8 | -64.9 | -187 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 67 | -7.04 | -63.1 | -67.6 | -194 |
| Financing Cash Flow Items | — | — | -0.677 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -45.4 | -34.6 | -82.8 | -26.1 | -26.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 199 | -16.2 | -177 | 23.1 | -51.8 |